Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
Status: Enrolling
Updated:  1/21/2016
Research Site
mi
from
Victoria,
A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
Status: Enrolling
Updated: 1/21/2016
Research Site
mi
from
Victoria,
Click here to add this to my saved trials
Rheumatic Diseases and Computer Use
Rheumatic Diseases and Computer Use: A Needs Assessment
Status: Enrolling
Updated:  1/21/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Rheumatic Diseases and Computer Use
Rheumatic Diseases and Computer Use: A Needs Assessment
Status: Enrolling
Updated: 1/21/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
OTIS Autoimmune Diseases in Pregnancy Project
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Status: Enrolling
Updated:  1/26/2016
The University of California, San Diego
mi
from
La Jolla, CA
OTIS Autoimmune Diseases in Pregnancy Project
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Status: Enrolling
Updated: 1/26/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Status: Enrolling
Updated:  1/30/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Status: Enrolling
Updated: 1/30/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Reciprocating Medical Devices - a Study of a New Safety Device
Randomized Controlled Trial of the Reciprocating Procedure Device Versus the Conventional Syringe in Syringe-and-Needle Procedures
Status: Enrolling
Updated:  2/2/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Reciprocating Medical Devices - a Study of a New Safety Device
Randomized Controlled Trial of the Reciprocating Procedure Device Versus the Conventional Syringe in Syringe-and-Needle Procedures
Status: Enrolling
Updated: 2/2/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
Status: Enrolling
Updated:  2/3/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
Status: Enrolling
Updated: 2/3/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Peoria, AZ
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Covina, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Covina, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
El Cajon, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Hemet, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Hemet, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Van Nuys, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Van Nuys, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Whittier, CA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Danbury, CT
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Miami, FL
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Orlando, FL
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Lexington, KY
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Hagerstown, MD
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Wheaton, MD
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Wheaton, MD
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Omaha, NE
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Reno, NV
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Brooklyn, NY
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Mineola, NY
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Duncansville, PA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Charleston, SC
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Memphis, TN
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Carrollton, TX
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Carrollton, TX
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Dallas, TX
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Spokane, WA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Huntsville, AL
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Sarasota, FL
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated:  2/3/2016
Research Site
mi
from
Soifia,
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Status: Enrolling
Updated: 2/3/2016
Research Site
mi
from
Soifia,
Click here to add this to my saved trials
Long-term Observation of Patients With Early Rheumatoid Arthritis
Long-term Observation of Patients With Early Rheumatoid Arthritis
Status: Enrolling
Updated:  2/17/2016
UCLA
mi
from
Los Angeles, CA
Long-term Observation of Patients With Early Rheumatoid Arthritis
Long-term Observation of Patients With Early Rheumatoid Arthritis
Status: Enrolling
Updated: 2/17/2016
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Birmingham, AL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Denver, CO
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Atlanta, GA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Meridian, ID
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Bismarck, ND
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Akron, OH
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Tuscaloosa, AL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Peoria, AZ
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Encino, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Hemet, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Hemet, CA
Click here to add this to my saved trials